About Oligo Medic
Oligo Medic was founded in 2010 by pioneers of chitosan as a material for biomedical applications, with over 25 years of experience developing medical devices.
Their earlier efforts culminated in the commercialization of BST-CarGel, a cartilage repair product acquired by Smith&Nephew.
Initially focused on its novel technology platform, Oligo Medic has developed a fully self-gelling injectable scaffold for cartilage repair. The company rapidly reached commercialization milestones for its first product JointRep including CE mark in 2014.
By 2021 there had been over 7000 patients treated in over 20 countries spanning Canada, Europe, Australia/New Zealand, Southeast Asia and Latin America. Growth potential for the JointRep platform includes use of JointRep for other body joints than the knee, and use of JointRep as a carrier for biologics (PRP, stem cells, etc.).
Oligo Medic operates under a Quality Management System compliant with the requirements of ISO13485:2016.
- Focus : Manufacturer
- Industry : Biotechnology
